Legislative record

SB 436STATE · TennesseeIntroduced

Drugs, Prescription - As enacted, adds mandating the use of biosimilar drugs as a cost-saving measure the bureau of TennCare may implement; adds that a health carrier, health benefit plan, or utilization review organization may require a patient to try a biosimilar product prior to providing coverage for the equivalent branded prescription drug; requires the TennCare pharmacy advisory committee to consider as a factor the use of biosimilar drugs in the committee's recommendation to the bureau of TennCare on any drugs to be added to the state preferred drug list. - Amends TCA Title 4; Title 53; Title 56; Title 68 and Title 71.

Voted 4/28/2025View source

Summary

No summary has been published for this bill yet.

Bill text

The full text of this bill isn't on Heard yet. The official documents are linked below.

Roll-call record

How representatives voted

9 yea·0 nay

Docket history

Action history

  1. 4/28/2025Comp. became Pub. Ch. 206
  2. 3/31/2025Companion House Bill substituted
  3. 3/28/2025Placed on Senate Regular Calendar for 3/31/2025
  4. 3/25/2025Recommended for passage with amendment/s, refer to Senate Calendar Committee Ayes 9, Nays 0 PNV 0
  5. 3/19/2025Placed on Senate Commerce and Labor Committee calendar for 3/25/2025
  6. 3/18/2025Action deferred in Senate Commerce and Labor Committee to 3/25/2025
  7. 3/13/2025Placed on Senate Commerce and Labor Committee calendar for 3/18/2025
  8. 3/11/2025Placed on Senate Commerce and Labor Committee calendar for 3/18/2025
  9. 2/12/2025Passed on Second Consideration, refer to Senate Commerce and Labor Committee
  10. 2/10/2025Introduced, Passed on First Consideration